SCHEMBL6793692

SCHEMBL6793692

O=C(CCc1cccnc1)c1ccc(NC(=O)c2ccccc2-c2ccc(C(F)(F)F)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 6/20 0.53
EPAS1 Q99814 6/20 0.53
EPHX2 P34913 1/20 0.51
TRPV1 Q8NER1 1/20 0.48
MTTP P55157 2/20 0.48
APOB P04114 2/20 0.48
KMT2A Q03164 2/20 0.47
HTT P42858 1/20 0.47
ADRB1 P08588 1/20 0.47
ADRB3 P13945 1/20 0.47
ALDH1A1 P00352 1/20 0.47
KDR P35968 1/20 0.46
PPARG P37231 1/20 0.46
PPARD Q03181 1/20 0.46
PPARA Q07869 1/20 0.46
NR1H4 Q96RI1 1/20 0.46
MEN1 O00255 1/20 0.46
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
XBP1 P17861 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6798640 0.88 HIF1A (0.53) HIF1AEPAS1EPHX2TRPV1MTTP
SCHEMBL6800223 0.88 ADRB1 (0.53) HIF1AEPAS1EPHX2MTTPAPOB
SCHEMBL6792412 0.84 ADRB3 (0.54) HIF1AEPAS1EPHX2MTTPAPOB
SCHEMBL6788349 0.83 SMO (0.59) TRPV1MTTPAPOBHTTALDH1A1
SCHEMBL6792347 0.80 NAMPT (0.54) HIF1AEPAS1EPHX2TRPV1MTTP
SCHEMBL6795714 0.79 TRPV1 (0.53) TRPV1MTTPAPOBALDH1A1KDR
SCHEMBL6793205 0.79 PTGS1 (0.47) TRPV1MTTPAPOBSMN1; SMN2
SCHEMBL7608638 0.78 KMT2A (0.58) EPHX2MTTPAPOBKMT2AHTT
SCHEMBL6793895 0.78 FFAR1 (0.57) MTTPAPOBALDH1A1PPARGPPARD
SCHEMBL6798035 0.78 HPGD (0.55) EPHX2TRPV1KMT2AHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-03-25 US disclosed
EP-1326835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-16 EP disclosed
WO-2002028835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-04-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors APOB, APOL1, SCARB1 HIF1A 4361/4885EPAS1 2569/4885EPHX2 2006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.